Gary Yeowell/DigitalVision via Getty Images Over the last couple of weeks, I have been looking for solid options for value investing overseas. I rarely buy individual foreign stocks, so ETFs are preferred. My first analysis covered the Cambria Global Value ETF ( GVAL ), an actively managed fund that invests primarily in emerging markets . I rated the fund as a Hold with some concerns about the ris...
Gary Yeowell/DigitalVision via Getty Images Over the last couple of weeks, I have been looking for solid options for value investing overseas. I rarely buy individual foreign stocks, so ETFs are preferred. My first analysis covered the Cambria Global Value ETF ( GVAL ), an actively managed fund that invests primarily in emerging markets . I rated the fund as a Hold with some concerns about the risks involved in ownership of stocks in less developed countries. A few days later, I wrote about the First Eagle Overseas Equity ETF ( FEOE ), giving it a similar rating . While the fund had strong recent returns, its short track record dampened some of my enthusiasm for its future results. My final candidate from the international value space is the DFA Dimensional International Value ETF ( DFIV ). Also, actively managed , the fund has a history that dates back to 1999. While no fund is perfect, DFIV certainly checks more boxes for me than GVAL or FEOE. Its strong recent returns and the characteristics of the stocks in its portfolio paint the picture of a fund that is well-positioned for success in the remainder of this year. I consider the DFA Dimensional International Value ETF to be a Buy for the reasons discussed below. ETF Overview Managed by Dimensional Fund Advisors, the DFA Dimensional International Value ETF has the stated objective of achieving “long-term capital appreciation while minimizing federal income taxes on returns.” The fund uses the MSCI World ex USA Value Index as its benchmark and generally holds 500 to 600 stocks in its portfolio. Dimensional uses traditional value metrics like price-to-book value and price-to-cash flow to identify the best candidates for selection in its portfolio, but it also factors in profitability and earnings growth to avoid the collection of “value traps.” When compared to its benchmark, the holdings in DFIV have a slightly lower market cap but also a lower price-to-book ratio. DFIV Fact Sheet As of May 3, DFIV had $19.3 billi...
OSI Systems press release ( OSIS ): Q3 Non-GAAP EPS of $2.60 beats by $0.06 . Revenue of $453M (+2.0% Y/Y) beats by $3.74M . Record Q3 Backlog of $1.9 Billion Q3 Book-to- Bill Ratio of 1.3x Company Reiterates its Fiscal 2026 Guidance More on OSI Systems OSI Systems, Inc. (OSIS) Presents at JPMorgan Industrials Conference 2026 Transcript OSI Systems, Inc. (OSIS) Presents at Morgan Stanley Technolog...
OSI Systems press release ( OSIS ): Q3 Non-GAAP EPS of $2.60 beats by $0.06 . Revenue of $453M (+2.0% Y/Y) beats by $3.74M . Record Q3 Backlog of $1.9 Billion Q3 Book-to- Bill Ratio of 1.3x Company Reiterates its Fiscal 2026 Guidance More on OSI Systems OSI Systems, Inc. (OSIS) Presents at JPMorgan Industrials Conference 2026 Transcript OSI Systems, Inc. (OSIS) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript OSI Systems, Inc. (OSIS) Presents at Citi's Global Industrial Tech & Mobility Conference 2026 Transcript OSI Systems gets $235M radar contract OSI Systems wins over $40M medical device components contract
Vornado Realty Trust press release ( VNO ): Q1 FFO of $0.52 beats by $0.01 . Revenue of $459.11M (-0.5% Y/Y) beats by $31.46M . More on Vornado Realty Trust Vornado Realty Dips As Manhattan Office Leasing Moves Up Vornado Realty: Reviewing The 7%+ Preferreds After The Latest Earnings Vornado Realty Trust (VNO) Q4 2025 Earnings Call Transcript Quant ratings uncover top & bottom mid-cap REIT stocks ...
Vornado Realty Trust press release ( VNO ): Q1 FFO of $0.52 beats by $0.01 . Revenue of $459.11M (-0.5% Y/Y) beats by $31.46M . More on Vornado Realty Trust Vornado Realty Dips As Manhattan Office Leasing Moves Up Vornado Realty: Reviewing The 7%+ Preferreds After The Latest Earnings Vornado Realty Trust (VNO) Q4 2025 Earnings Call Transcript Quant ratings uncover top & bottom mid-cap REIT stocks ahead of Q1 earnings Meta to open NYC retail store on Fifth Avenue
HAMPTON, N.H., May 04, 2026 (GLOBE NEWSWIRE) -- Unitil Corporation (NYSE: UTL) ( unitil.com ) today announced Net Income of $33.2 million, or $1.85 in Earnings Per Share (EPS) for the first quarter of 2026, an increase of $5.7 million in Net Income, or $0.16 in EPS, compared to the first quarter of 2025. The Company's Adjusted Net Income (a non-GAAP financial measure 1 ), which excluded transactio...
HAMPTON, N.H., May 04, 2026 (GLOBE NEWSWIRE) -- Unitil Corporation (NYSE: UTL) ( unitil.com ) today announced Net Income of $33.2 million, or $1.85 in Earnings Per Share (EPS) for the first quarter of 2026, an increase of $5.7 million in Net Income, or $0.16 in EPS, compared to the first quarter of 2025. The Company's Adjusted Net Income (a non-GAAP financial measure 1 ), which excluded transaction-related costs in connection with the acquisitions of Bangor Natural Gas Company (Bangor), Maine Natural Gas Company (Maine Natural) and Aquarion Water Company of Massachusetts, Inc., Aquarion Water Company of New Hampshire, Inc., and Abenaki Water Co., Inc. (the Aquarion Companies), was $33.8 million, or $1.88 in EPS, for the first quarter of 2026, an increase of $5.4 million, or $0.14 in EPS, compared to the first quarter of 2025.
ZUG, Switzerland and BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the first quarter ended March 31, 2026.
ZUG, Switzerland and BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the first quarter ended March 31, 2026.
AbbVie (NYSE: ABBV) has not performed well this year, but the company's recent first-quarter update, released on April 29, helped breathe new life into the stock, which jumped by more than 3% post-earnings. Could this be the start of a sustained rally? It's hard to say. However, AbbVie's financial results once again highlighted one of the company's strengths that investors should pay attention to....
AbbVie (NYSE: ABBV) has not performed well this year, but the company's recent first-quarter update, released on April 29, helped breathe new life into the stock, which jumped by more than 3% post-earnings. Could this be the start of a sustained rally? It's hard to say. However, AbbVie's financial results once again highlighted one of the company's strengths that investors should pay attention to. Let's look into it and consider what it means for AbbVie's prospects. Image source: The Motley Fool. AbbVie's revenue for the first quarter came in at $15 billion, 12.4% higher than the year-ago period. The company had projected sales of $14.7 billion for the period, so this is a nice surprise. The pharmaceutical leader singled out several areas that drove the revenue beat, including its immunology business. That's the trend investors shouldn't miss. AbbVie has been a leader in immunology for a while, dating back to the days when Humira -- once the world's best-selling drug -- was its biggest growth driver. Continue reading
(RTTNews) - Canadian stocks moved lower on Monday as investors refrained from big bets after the U.S. and Iran pushed to re-assert control over the Strait of Hormuz. The intensifying conflict pushed oil prices and inflationary concerns higher once again.
(RTTNews) - Canadian stocks moved lower on Monday as investors refrained from big bets after the U.S. and Iran pushed to re-assert control over the Strait of Hormuz. The intensifying conflict pushed oil prices and inflationary concerns higher once again.
jetcityimage/iStock Editorial via Getty Images Progressive ( PGR ) saw its first-quarter earnings miss estimates as the insurer grew fewer policies in force than expected. The property and casualty insurer reported an 8% year-over-year growth in Q1 net premiums earned to $20.97B, modestly above the Visible Alpha consensus of $20.72B. Net premiums written rose 6% to $23.64B from $22.21B, compared t...
jetcityimage/iStock Editorial via Getty Images Progressive ( PGR ) saw its first-quarter earnings miss estimates as the insurer grew fewer policies in force than expected. The property and casualty insurer reported an 8% year-over-year growth in Q1 net premiums earned to $20.97B, modestly above the Visible Alpha consensus of $20.72B. Net premiums written rose 6% to $23.64B from $22.21B, compared to the consensus of $23.30B. Catastrophe losses fell to $268M during the quarter from $459M a year ago. Net income per share available to common shareholders rose 10% to $4.80 from $4.37, but remained below the analysts consensus of $4.97. Total policies in force increased 9% to 39.57M from 36.29M but were slightly below the average analyst estimate of 39.58M. The miss in PIF was driven by the Property segment that reported 3.64M policies in force as of March 31, against expectations of 3.66M, and the Direct - Personal Auto segment that reported policies of 16.57M against the 16.59M consensus. Growth in the Property segment was partially offset by intentional actions taken to moderate growth in homeowners’ products, CEO Tricia Griffith said in the shareholders letter. For the commercial auto industry, the Mayfield, Ohio-based company believes competitors are increasing rates and taking other underwriting actions. "We expect our pricing to become more competitive," Griffith said in the letter. More on Progressive Progressive Stock Crash Explained: Strong Business, Falling Shares? Progressive: Sentiment Is Too Negative Given Underlying Results Progressive: Moderating Growth But Intact Fundamentals Progressive Q1 2026 Earnings Preview Progressive prices $1.5B senior notes offering across 2031, 2036 maturities
ThredUp press release ( TDUP ): Q1 GAAP EPS of -$0.05 in-line. Revenue of $81.7M (+14.6% Y/Y) beats by $1.54M . Ended the quarter with cash and cash equivalents, restricted cash, and marketable securities of $54.4 million, up 1.3 million from the previous quarter Financial Outlook For the second quarter 2026, ThredUp expects: Revenue in the range of $89.0 million to $91.0 million, +16% year-over-y...
ThredUp press release ( TDUP ): Q1 GAAP EPS of -$0.05 in-line. Revenue of $81.7M (+14.6% Y/Y) beats by $1.54M . Ended the quarter with cash and cash equivalents, restricted cash, and marketable securities of $54.4 million, up 1.3 million from the previous quarter Financial Outlook For the second quarter 2026, ThredUp expects: Revenue in the range of $89.0 million to $91.0 million, +16% year-over-year at the midpoint Gross margin in the range of 78.5% to 79.5% Adjusted EBITDA margin of approximately 5.2% For the full fiscal year 2026, ThredUp expects: Revenue in the range of $351.2 million to $356.2 million, +14% year-over-year at the midpoint Gross margin in the range of 78.5% to 79.5% Adjusted EBITDA margin of approximately 6.1% More on ThredUp ThredUp: Strong Thrifting Demand Underlies Falling Valuation ThredUp Inc. (TDUP) Q4 2025 Earnings Call Transcript ThredUp Inc. 2025 Q4 - Results - Earnings Call Presentation Quant check on e-commerce names as GameStop offers to buy eBay ThredUp gains amid positive outlook for the U.S. resale industry
Palantir Technologies Inc (NYSE:PLTR) reported first quarter results on Monday that exceeded analyst expectations on both earnings and revenue, driven by strong growth in its US business, particularly in the commercial segment. The data analytics firm posted adjusted earnings per share of...
Palantir Technologies Inc (NYSE:PLTR) reported first quarter results on Monday that exceeded analyst expectations on both earnings and revenue, driven by strong growth in its US business, particularly in the commercial segment. The data analytics firm posted adjusted earnings per share of...
Ocugen ( OCGN ) announced on Monday that it plans to raise about $115M through Convertible Senior Notes due 2034 in a private placement to qualified institutional buyers. Additionally, it also plans a 13-day option for the initial purchaser to raise an additional $15M in notes if demand allows. The company will use ~$32.7M of net proceeds to fully repay its existing debt with affiliates of Avenue ...
Ocugen ( OCGN ) announced on Monday that it plans to raise about $115M through Convertible Senior Notes due 2034 in a private placement to qualified institutional buyers. Additionally, it also plans a 13-day option for the initial purchaser to raise an additional $15M in notes if demand allows. The company will use ~$32.7M of net proceeds to fully repay its existing debt with affiliates of Avenue Capital Group, helping reduce near-term debt. On the other hand, the remaining net proceeds from the initial purchaser will be deployed for general corporate purposes. The notes may be converted into cash, shares, or a mix, with the final interest rate and conversion ratio still to be decided at pricing. The deal remains subject to market conditions and is not finalized yet. Following the news, the stock traded at ~$1.64 while dropping ~12% in after-hours. Source: Press Release More on Ocugen Ocugen, Inc. (OCGN) Discusses Top Line Results From Phase II ArMaDa Trial of OCU410 in Geographic Atrophy Transcript Ocugen: Downgrading After OCU410 Data Release Ocugen, Inc. (OCGN) Q4 2025 Earnings Call Transcript Ocugen Q1 2026 Earnings Preview Ocugen falls after 12-month data from mid-stage trial for GA therapy
RB Global press release ( RBA ): Q1 Non-GAAP EPS of $1.01 beats by $0.04 . Revenue of $1.2B (+9.1% Y/Y) beats by $50M . Net income increased 20% year over year to $135.6 million. Net income available to common stockholders increased 21% year over year to $124.6 million. 2026 Financial Outlook The Company has updated its full-year 2026 outlook for select financial data, as shown below: (in millions...
RB Global press release ( RBA ): Q1 Non-GAAP EPS of $1.01 beats by $0.04 . Revenue of $1.2B (+9.1% Y/Y) beats by $50M . Net income increased 20% year over year to $135.6 million. Net income available to common stockholders increased 21% year over year to $124.6 million. 2026 Financial Outlook The Company has updated its full-year 2026 outlook for select financial data, as shown below: (in millions, except percentages) Current Outlook Prior Outlook GTV growth 6% to 9% 5% to 8% Adjusted EBITDA $1,485 to $1,545 $1,470 to $1,530 Full year tax rate (GAAP and adjusted) 23% to 25% 23% to 25% Capital expenditures4 $350 to $400 $350 to $400 Click to enlarge Click to enlarge More on RB Global RB Global: Improving Business Mix, Limited Valuation Upside RB Global, Inc. (RBA) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript RB Global, Inc. 2025 Q4 - Results - Earnings Call Presentation RB Global to acquire Bigiron RB Global outlines 5–8% GTV growth target for 2026 with focus on market share gains and AI-driven initiatives
Golub Capital BDC press release ( GBDC ): Q2 adjusted net investment income per share of $0.34. Total investment income of $188.13M. Net asset value (“NAV”) per share decreased to $14.35 at March 31, 2026 from $14.84 at December 31, 2025. On May 1, 2026, our board of directors declared a quarterly distribution of $0.33 per share, which is payable on June 29, 2026, to stockholders of record as of J...
Golub Capital BDC press release ( GBDC ): Q2 adjusted net investment income per share of $0.34. Total investment income of $188.13M. Net asset value (“NAV”) per share decreased to $14.35 at March 31, 2026 from $14.84 at December 31, 2025. On May 1, 2026, our board of directors declared a quarterly distribution of $0.33 per share, which is payable on June 29, 2026, to stockholders of record as of June 15, 2026. During the three months ended March 31, 2026, we opportunistically repurchased approximately 2,236,904 shares of our common stock for an aggregate purchase price of approximately $27.8 million, at an aggregate price of $12.43 per share, and during the period April 1, 2026 through May 4, 2026 we repurchased approximately 0.7 million shares of our common stock for an aggregate purchase price of approximately $8.4 million, at an aggregate price of $12.93 per share in response to market volatility. During the three months ended March 31, 2026, the Golub Capital Employee Grant Program Rabbi Trust (the “Trust”) purchased approximately $18.7 million, or 1,500,000 shares, of our common stock for the purpose of awarding incentive compensation to employees of Golub Capital. During the calendar year 2025, the Trust purchased approximately $45.1 million or 3,089,459 shares, of our common stock. More on Golub Capital BDC Golub Capital BDC: An Underrated Opportunity In The BDC Sector Golub Capital: High Yield And Significant Discount Make It A Buy Golub Capital: The Dividend Cut Took Place As Projected, But I'm Still Not Buying Golub Capital BDC Q2 2026 Earnings Preview RBC Capital Markets initiates coverage of Golub Capital with Buy-equivalent